Andere Sprachen Elanco Animal Health Incorporated

Aktien

A2N6BH

US28414H1032

ELAN

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 18.04.2024			% 5 Tage	% 1. Jan.
13,57 ^USD	+1,19 %		-8,00 %	-8,93 %

01.04.	Elanco Animal Health beruft zwei von Ancora Holdings nominierte Mitglieder in den Vorstand	MT
01.04.	Elanco ernennt zwei Direktoren nach der Einigung mit dem Aktivisten Ancora	RE

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement	17.04.
Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board	01.04.
Elanco llega a un acuerdo con el activista Ancora -- Market Talk	01.04.
Elanco appoints two directors after settling with activist Ancora	01.04.
Elanco appoints two directors to its board after agreement with Ancora	01.04.
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors	01.04.
Elanco Animal Health Incorporated Appoints Kathy Turner and Craig Wallace, to Its Board of Directors	01.04.
Elanco Animal Health Enters into Cooperation Agreement with Ancora Advisors	01.04.
Activist investor Ancora secures two Elanco board seats, Bloomberg News reports	01.04.
Elanco Animal Health Insider Bought Shares Worth $322,808, According to a Recent SEC Filing	08.03.
Elanco Appoints Shiv O'Neill as General Counsel and Corporate Secretary	04.03.
Elanco Animal Health Incorporated Appoints Shiv O'Neill as Executive Vice President, General Counsel and Corporate Secretary	04.03.
Elanco Animal Health Incorporated Sends Communication to its Employees	29.02.
Elanco Animal Health Incorporated Issues a Statement in Response to the Submission of Nominees by Ancora Holdings Group	29.02.
Ancora seeks four board seats at Elanco amid push for changes	29.02.
Elanco Animal Health Issues Response to Ancora Holdings' Board Nominations	29.02.
Elanco Animal Health is Executing on Plan to Deliver for Shareholders	29.02.
Elanco Animal Health Shareholder Ancora Pushes for Board Refresh, Chief Executive Succession Plan	29.02.
Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health	29.02.
Ancora Nominates Candidates to Elanco Animal Health Board	29.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Elanco Animal Health Incorporated

Aktien

A2N6BH

US28414H1032

ELAN

Andere Sprachen

Filter